5 Stocks Pushing The Health Services Industry Higher

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 87 points (-0.6%) at 14,874 as of Thursday, June 6, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,317 issues advancing vs. 1,603 declining with 125 unchanged.

The Health Services industry currently sits down 0.59 versus the S&P 500, which is down 0.38. Top gainers within the industry include LifePoint Hospitals ( LPNT), up 3.6%, Tenet Healthcare ( THC), up 1.8%, Covance ( CVD), up 1.7%, Smith & Nephew ( SNN), up 1.3% and Fresenius Medical Care AG & Co. KGaA ( FMS), up 0.8%. On the negative front, top decliners within the industry include ResMed ( RMD), down 3.57, and Becton Dickinson ( BDX), down 0.63.

TheStreet Ratings group would like to highlight 5 stocks pushing the industry higher today:

5. Mettler-Toledo International ( MTD) is one of the companies pushing the Health Services industry higher today. As of noon trading, Mettler-Toledo International is up $2.05 (0.97) to $214.21 on average volume Thus far, 77,684 shares of Mettler-Toledo International exchanged hands as compared to its average daily volume of 200,200 shares. The stock has ranged in price between $211.85-$215.48 after having opened the day at $211.85 as compared to the previous trading day's close of $212.16.

Mettler-Toledo International Inc. supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. Mettler-Toledo International has a market cap of $6.5 billion and is part of the health care sector. The company has a P/E ratio of 23.4, above the S&P 500 P/E ratio of 17.7. Shares are up 9.8% year to date as of the close of trading on Wednesday. Currently there are 3 analysts that rate Mettler-Toledo International a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Mettler-Toledo International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, notable return on equity, good cash flow from operations, growth in earnings per share and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Mettler-Toledo International Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Community Health Systems ( CYH) is up $0.52 (1.10) to $47.61 on average volume Thus far, 602,185 shares of Community Health Systems exchanged hands as compared to its average daily volume of 1.2 million shares. The stock has ranged in price between $46.68-$48.44 after having opened the day at $47.08 as compared to the previous trading day's close of $47.09.

Community Health Systems, Inc., together with its subsidiaries, provides general and specialized hospital healthcare services to patients in the United States. Community Health Systems has a market cap of $4.5 billion and is part of the health care sector. The company has a P/E ratio of 16.1, below the S&P 500 P/E ratio of 17.7. Shares are up 53.2% year to date as of the close of trading on Wednesday. Currently there are 9 analysts that rate Community Health Systems a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Community Health Systems as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, revenue growth, attractive valuation levels and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Community Health Systems Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, DaVita HealthCare Partners ( DVA) is up $0.76 (0.62) to $123.88 on average volume Thus far, 331,845 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 787,800 shares. The stock has ranged in price between $122.57-$124.93 after having opened the day at $123.20 as compared to the previous trading day's close of $123.12.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $13.2 billion and is part of the health care sector. The company has a P/E ratio of 30.0, above the S&P 500 P/E ratio of 17.7. Shares are up 11.4% year to date as of the close of trading on Wednesday. Currently there are 9 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full DaVita HealthCare Partners Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Aetna ( AET) is up $0.59 (1.01) to $58.81 on average volume Thus far, 1.5 million shares of Aetna exchanged hands as compared to its average daily volume of 3.2 million shares. The stock has ranged in price between $57.96-$59.24 after having opened the day at $58.42 as compared to the previous trading day's close of $58.22.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $19.3 billion and is part of the health care sector. The company has a P/E ratio of 12.2, below the S&P 500 P/E ratio of 17.7. Shares are up 25.7% year to date as of the close of trading on Wednesday. Currently there are 9 analysts that rate Aetna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, attractive valuation levels, largely solid financial position with reasonable debt levels by most measures and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Aetna Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Intuitive Surgical ( ISRG) is up $4.25 (0.85) to $504.79 on light volume Thus far, 110,768 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 470,300 shares. The stock has ranged in price between $499.36-$506.34 after having opened the day at $501.87 as compared to the previous trading day's close of $500.54.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $20.0 billion and is part of the health care sector. The company has a P/E ratio of 29.3, above the S&P 500 P/E ratio of 17.7. Shares are up 1.7% year to date as of the close of trading on Wednesday. Currently there are 11 analysts that rate Intuitive Surgical a buy, 1 analyst rates it a sell, and 3 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Intuitive Surgical Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%